Estrogen Receptor and Claudin-6 Might Play Vital Roles for Long-Term Prognosis in Patients With Luminal A Breast Cancer Who Underwent Neoadjuvant Chemotherapy

PURPOSE: It is well-known that the pathological complete response (pCR) rate in patients with luminal A cancer (LAC) is lower than those of other subtypes of breast cancer. The phenotype of cancer often alters after neoadjuvant chemotherapy (NAC) which may be related to hypoxia, and the latter might...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yushi, Kang, Ye, Li, Jianyi, Zhang, Yang, Jia, Shi, Sun, Qiang, Ma, Yan, Zhang, Jing, Wang, Zhenrong, Cao, Yanan, Shen, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280129/
https://www.ncbi.nlm.nih.gov/pubmed/35847894
http://dx.doi.org/10.3389/fonc.2022.630065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280129/
https://www.ncbi.nlm.nih.gov/pubmed/35847894
http://dx.doi.org/10.3389/fonc.2022.630065

Ejemplares similares